Develops pharmaceutical drugs for treating cancer & inflammatory diseases
CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market.
The Company operates through one business segment, which is the development of targeted therapeutics primarily for the treatment of cancer.
The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau.
The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.
CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.